Pricing Log in Create free account
Saturday 17 October 2026 Export BIIB’s income statement to Excel — free account

Biogen Inc.

BIIB Healthcare Drug Manufacturers General

Biogen Inc.’s revenue for fiscal 2025 (year ended December 2025) was $9.9 billion, up 2.22% from fiscal 2024. In the quarter to June 2026, revenue grew 3.42%, EPS fell 84.8%, free cash flow grew 103.3% and total debt rose 16.0%, each against the same quarter a year earlier. Member of the S&P 500; insiders bought in the last twelve months.

232.65 2.70 −1.15%
Market cap
$34.8B
P/E
41.0×
Fwd P/E
31.5×
Dividend yield
—
F-score
4/9
Altman Z
3.13
Beneish M
−2.67
Dividend safety
n/a
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

Biogen Inc. (BIIB) P/S ratio

Alert me on P/S ratio

As of 16 October 2026, Biogen Inc. (BIIB) trades at a P/S ratio of 3.4×. Over the past ten years it has ranged from 1.7× (April 2025) to 11.6× (March 2015); the current reading is higher than 43% of that period. That is in line with the Drug Manufacturers General industry median of 3.4× and in line with the Healthcare sector median of 3.4×.

P/S ratio, daily

Embed this chart

Annual newest first

Period P/S ratio Change
FY2025 2.6× 13.28%
FY2024 2.3× (41.57%)
FY2023 3.9× 1.15%
FY2022 3.9× 19.54%
FY2021 3.3× 11.16%
FY2020 2.9× (24.11%)
FY2019 3.9× (15.75%)
FY2018 4.6× (20.82%)
FY2017 5.8× 4.02%
FY2016 5.6× (15.25%)

Quarterly newest first

Period P/S ratio Change
Jun 2026 3.2× 17.19%
Mar 2026 2.7× 4.17%
Dec 2025 2.6× 27.78%
Sep 2025 2.0× 10.85%
42 more quarters

Against its own ten years

Low 1.7× High 11.6×
Ten-year median 3.7×
Current reading's percentile 47

P/S ratio against peers

Company P/S ratio
SNY Sanofi compare 1.7×
GSK GSK PLC Sponsored ADR compare 2.2×
BMY Bristol Myers Squibb Company compare 2.5×
PFE Pfizer Inc. compare 2.6×
NVO Novo Nordisk A/S compare 3.3×
BIIB Biogen Inc. 3.4×
AZN AstraZeneca PLC compare 4.2×
AMGN Amgen Inc. compare 6.1×
GILD Gilead Sciences, Inc. compare 6.4×
Drug Manufacturers General industry median 3.4×
Healthcare sector median 3.4×
Market median 1.9×

What P/S ratio is

Price to Sales Ratio shows how much investors pay for each dollar of a company’s annual sales, whether or not it is profitable.

(Stock Price × Shares (Basic, Weighted) (latest quarter)) ÷ Revenue (TTM)

The full definition of P/S ratio →

More on BIIB